TCT 2019 : SCOPE I Trial

Published: 15 Oct 2019

  • Views:

    Views Icon 315
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating


Dr Jonas Lanz (University of Bern, Bern, SW) discusses - SCOPE-I: A Randomized Trial of the ACURATE neo vs. the SAPIEN 3 Bioprosthesis in Patients With Severe Aortic Stenosis.

Questions :
1. What is the SCOPE-I study?
2. What were your findings?
3. What were the stroke rates?
4. Is the ACURATE neo option still a valuable option to implanters?

Filmed on site at TCT 2019 by Radcliffe Cardiology

Videographer: Josh Birch
Interviewer: Liam O’Neill